BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 16, 2018
View Archived Issues
Microbiome affects rotavirus vaccine immunogenicity
Read More
TAC versus CAR
Read More
RAPTA-T pretreatment enhances tumor vascular function and cisplatin uptake in pleural mesothelioma
Read More
Discovery of a biomarker that correlates with psychopathy and cognition in schizophrenia
Read More
Identification of a gene that drives progression and metastases in KRAS-driven lung cancer
Read More
Preclinical studies identify a potential drug target for the treatment of neuroblastoma
Read More
First patient treated in Escalier Biosciences' phase I/IIa study of ESR-114
Read More
Entasis announces positive topline phase II data for ETX-2514 plus sulbactam in patients with cUTI
Read More
Brain immune cells mediate arthritic joint pain
Read More
IND approval received in China for phase Ib/III study of CAN-017 as treatment of ESCC
Read More
Hefei Institutes of Physical Sciences divulges EZH2 inhibitors
Read More
Proteasome inhibitors patented by Chengdu Origin Biotechnology
Read More
Shanghai Longwood Biopharmaceuticals identifies hepatitis B caspid assembly inhibitors
Read More
Nuclear receptor ROR-gamma inverse agonists discovered at Genfit
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical describe TLR7 agonists
Read More
First patients dosed in phase I/II study of TLC-590 for postsurgical pain management
Read More
BHV-0223 reduces anxiety in proof-of-concept trial
Read More
Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months
Read More
Phase II trial of AG-013 in oral mucositis resumes
Read More
Cabotegravir/rilpivirine regimen shows noninferiority to three-drug regimen for HIV infection
Read More
